Clinical Trial Update: Effect of 48 Hours of Treatment With the Natural Peptide-Hormone GLP-1 in Patients With Chronic Heart Failure [NA]

View source ↗

Summary

A clinical trial evaluating 48 hours of treatment with glucagon-like peptide-1 (GLP-1) in patients with chronic heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• GLP-1 (glucagon-like peptide-1)

Snippet

Sponsor: Aarhus University Hospital Skejby | Conditions: Heart Failure, Congestive | NA | Status: COMPLETED